Cargando…
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
BACKGROUND: Oligomeric forms of amyloid-β (Aβ) and tau are increasing being recognized as key toxins in the pathogenesis of Alzheimer’s disease (AD). METHODS: We developed a novel monoclonal antibody (mAb), GW-23B7, that recognizes β-sheet secondary structure on pathological oligomers of neurodegene...
Autores principales: | Goñi, Fernando, Martá-Ariza, Mitchell, Herline, Krystal, Peyser, Daniel, Boutajangout, Allal, Mehta, Pankaj, Drummond, Eleanor, Prelli, Frances, Wisniewski, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789573/ https://www.ncbi.nlm.nih.gov/pubmed/29378642 http://dx.doi.org/10.1186/s13195-018-0337-3 |
Ejemplares similares
-
Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases
por: Goñi, Fernando, et al.
Publicado: (2017) -
Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models
por: Goñi, Fernando, et al.
Publicado: (2013) -
Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer’s Mouse Model With Tau Pathology
por: Boutajangout, Allal, et al.
Publicado: (2021) -
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
por: Herline, Krystal, et al.
Publicado: (2018) -
The Innate Immune System in Alzheimer's Disease
por: Boutajangout, Allal, et al.
Publicado: (2013)